MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings
Gross Proceeds of $30.5 Million RaisedYAVNE, Israel, Oct. 07, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully integrated...
News
Alpesh Patel, CEO of Ravkoo, Joins Forces to Discuss Affordable Telehealthcare at ConV2X
Alpesh Patel, CEO of Ravkoo, Joins Forces to Discuss Affordable Telehealthcare at ConV2X Alpesh Patel, CEO of Ravkoo, Joins Forces...
NRC Health Announces Sponsorship of Creative Learning Event Series Hosted by the Society for Participatory Medicine
Year-Long, Four-Part Event Series Aims to Accelerate the Participatory Medicine Movement to Foster Deeper Patient-Provider RelationshipsLINCOLN, Neb., Sept. 29, 2022...
Wellframe and Linkwell Health Launch Wellsquared to Close the Gap Between Health Plans and their Members
Wellsquared helps health plans communicate with members through their preferred channels to build relationships and improve engagementBOSTON, Sept. 29, 2022...
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
LAVAL, Québec, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST),...
Icario’s Medicaid Redetermination Solution Helps Plans Prepare & Guide Members to Maintain Coverage
Advisory Services Combined with Medicaid Outreach Expertise at Scale Enable Plans to Optimize Efforts From Start to Finish Across Their...
Motus GI Named a Sole Source Supplier with U.S. Department of Veteran Affairs
Multiple contracts with VA medical centers already executed for Pure-Vu EVS under the sole source supplier designation, with additional centers...
Biosplice Therapeutics Announced New Clinical Data for Cirtuvivint (SM08502) at the European Society for Clinical Oncology Meeting
Results showed evidence of clinical activity for cirtuvivint in advanced cancer patientsSAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Biosplice...
Panbela Receives Approvals to Open Trial Sites in Spain, France and Italy for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
MINNEAPOLIS, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...
metaMe Health partners with Launchit Ventures to market Regulora, an FDA-cleared Prescription Digital Therapeutic for adults with IBS, in Canada
metaMe Health licenses rights to commercialization of Regulora in Canada to Launchit Ventures, Inc. to expedite the availability of Regulora...
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
Pre-emptive pay off of the Senior Secured Notes (the “Notes”) eliminated the prior $28.0 million increase in the principal amount...
Little Leaves Behavioral Services Opens New Location in Lutherville, Maryland
ABA therapy center meets growing need for high-quality, early intervention resources for young children with autismLUTHERVILLE, Md., Sept. 29, 2022...
The Annual Miracles for Myeloma 5K Hybrid Run/Walk Celebrates 10th Anniversary
CLARK, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Annual Miracles for Myeloma 5K Hybrid Run/Walk will be celebrating its...
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
SALT LAKE CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine,...
PolyPid Announces Eligibility for European Medicines Agency Centralized Procedure for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Surgery
Centralized Procedure Allows for Submission of a Single Marketing Application to the European Medicines Agency that, if Approved, Would Allow...
Oncotelic Presenting Data for OT101 Against Pancreatic Cancer (PDAC) at the SITC 37th Annual Meeting
AGOURA HILLS, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments...
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
Las Vegas, Nevada, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a...
Sight Sciences to Feature Interactive Panel Discussions of Real-World Use of the OMNI Surgical System as a Standalone (Non-Combination Cataract) Glaucoma Treatment at American Academy of Ophthalmology Annual Meeting
First-time Preview of the Ergo-Series of the OMNI® Surgical System and Exhibition of the New SION™ Surgical Instrument to be...
MaxCyte Signs Strategic Platform License with Vertex Pharmaceuticals to Advance CRISPR/Cas9-based Gene-editing Program
Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support gene-edited cell therapy exa-cel, formerly...
RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company...